Angiogenesis
Studies from University of Pennsylvania yield new data on angiogenesis
Published in Clinical Trials Week, December 18th, 2006
Investigators publish new data in the report "Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006). Activation of the Raf-MEK-ERK signal transduction pathway in endothelial cells is required for angiogenesis. Raf is the kinase most efficiently inhibited by the multikinase inhibitor sorafenib, which has shown activity against certain human cancers in clinical trials," scientists writing in the American Journal of Pathology report.
"To understand the mechanisms underlying this activity, we studied how it controlled growth of K1735 murine melanomas. Therapy caused massive regional tumor cell death accompanied by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2006-12-18)
More Articles from Clinical Trials Week
- Drug Development
Seattle Genetics initiates phase 1 trial of SGN-35 in Hodgkin, other hematologic malignancies - Dupuytren Contracture
Auxilium Pharmaceuticals initiates phase III trials for AA4500 in hand condition - Alcoholism Clinical Trial
Reports on alcoholism clinical trial findings from University of Pennsylvania, Department of Psychiatry provide new insights - Arthritis Clinical Trial
Researchers from Vanderbilt University describe findings in arthritis clinical trial - Breast Cancer Quality of Care
New breast cancer quality of care study findings have been reported from Stanford University - Breast Cancer Quality of Care
New findings from Fred Hutchinson Cancer Research Center describe advances in breast cancer quality of care - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
